SUPRATENTORIAL MALIGNANT GLIOMA - PATTERNS OF RECURRENCE AND IMPLICATIONS FOR EXTERNAL BEAM LOCAL TREATMENT

被引:231
作者
GASPAR, LE
FISHER, BJ
MACDONALD, DR
LEBER, DV
HALPERIN, EC
SCHOLD, SC
CAIRNCROSS, JG
机构
[1] UNIV WESTERN ONTARIO,DEPT ONCOL,LONDON N6A 3K7,ONTARIO,CANADA
[2] UNIV WESTERN ONTARIO,DEPT CLIN NEUROL SCI,LONDON N6A 3K7,ONTARIO,CANADA
[3] DUKE UNIV,MED CTR,DEPT RADIAT ONCOL,DURHAM,NC 27710
[4] DUKE UNIV,MED CTR,DEPT MED NEUROL,DURHAM,NC 27710
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1992年 / 24卷 / 01期
关键词
MALIGNANT GLIOMA; RADIOTHERAPY; RECURRENCE; BOOST FIELD;
D O I
10.1016/0360-3016(92)91021-E
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pre- and postoperative computerized tomography scans, simulator films, and computerized tomography scans documenting tumor recurrence were analyzed on 70 patients with supratentorial malignant glioma treated with whole brain plus boost radiation therapy to determine sites of recurrence in relation to the boost. The boost was planned using the postoperative computerized tomography scan. Tumor recurred in 53 patients-within the boost in 38 (72%), partly outside the boost in 12 (23%), outside the boost but within the brain in one (2%), in the boost and in the spinal cord in one (2%), and in the spinal cord only in one (2%). All recurrences confined to the brain were found within 4 cm of the enhancing tumor as defined by the preoperative computerized tomography scan. Recurrences outside the boost were more common with inadequate boost margins, small boost volumes, temporal lobe tumors, and homolateral wedge pair technique. Survival was not adversely affected by recurrence outside the boost. We recommend that patients with malignant glioma be treated by parallel opposed fields with a margin that is 4 cm beyond the edge of the preoperative enhancing tumor, as seen on computerized tomography scan.
引用
收藏
页码:55 / 57
页数:3
相关论文
共 8 条
[1]  
BURGER PC, 1983, J NEUROSURG, V58, P159, DOI 10.3171/jns.1983.58.2.0159
[2]   DEVELOPMENT OF MULTIPLE LESIONS DURING RADIATION-THERAPY AND CHEMOTHERAPY IN PATIENTS WITH GLIOMAS [J].
CHOUCAIR, AK ;
LEVIN, VA ;
GUTIN, PH ;
DAVIS, RL ;
SILVER, P ;
EDWARDS, MSB ;
WILSON, CB .
JOURNAL OF NEUROSURGERY, 1986, 65 (05) :654-658
[3]  
GREEN S B, 1986, Proceedings American Society of Clinical Oncology Annual Meeting, V5, P135
[4]   RADIATION-THERAPY TREATMENT PLANNING IN SUPRATENTORIAL GLIOBLASTOMA-MULTIFORME - AN ANALYSIS BASED ON POST-MORTEM TOPOGRAPHIC ANATOMY WITH CT CORRELATIONS [J].
HALPERIN, EC ;
BENTEL, G ;
HEINZ, ER ;
BURGER, PC .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 17 (06) :1347-1350
[5]   ASSUMPTIONS IN THE RADIOTHERAPY OF GLIOBLASTOMA [J].
HOCHBERG, FH ;
PRUITT, A .
NEUROLOGY, 1980, 30 (09) :907-911
[6]   RADIATION AND NITROIMIDAZOLES IN SUPRATENTORIAL HIGH-GRADE GLIOMAS - A 2ND CLINICAL-TRIAL [J].
URTASUN, R ;
FELDSTEIN, ML ;
PARTINGTON, J ;
TANASICHUK, H ;
MILLER, JDR ;
RUSSELL, DB ;
AGBOOLA, O ;
MIELKE, B .
BRITISH JOURNAL OF CANCER, 1982, 46 (01) :101-108
[7]   SUPRATENTORIAL ANAPLASTIC GLIOMAS IN ADULTS - THE PROGNOSTIC IMPORTANCE OF EXTENT OF RESECTION AND PRIOR LOW-GRADE GLIOMA [J].
WINGER, MJ ;
MACDONALD, DR ;
CAIRNCROSS, JG .
JOURNAL OF NEUROSURGERY, 1989, 71 (04) :487-493
[8]   SELECTION BIAS IN CLINICAL-TRIALS OF ANAPLASTIC GLIOMA [J].
WINGER, MJ ;
MACDONALD, DR ;
SCHOLD, SC ;
CAIRNCROSS, JG .
ANNALS OF NEUROLOGY, 1989, 26 (04) :531-534